Park Edge Advisors LLC Purchases Shares of 10,489 LifeStance Health Group, Inc. (NASDAQ:LFST)

Park Edge Advisors LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ:LFST) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 10,489 shares of the company’s stock, valued at approximately $73,000.

Other institutional investors also recently made changes to their positions in the company. Point72 Asset Management L.P. purchased a new position in shares of LifeStance Health Group in the second quarter worth about $4,326,000. Dimensional Fund Advisors LP grew its position in LifeStance Health Group by 82.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock worth $4,991,000 after acquiring an additional 457,930 shares during the last quarter. Magnetar Financial LLC purchased a new position in LifeStance Health Group in the 2nd quarter worth approximately $762,000. TD Asset Management Inc bought a new stake in LifeStance Health Group in the second quarter valued at approximately $623,000. Finally, Sei Investments Co. purchased a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $477,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on LFST. UBS Group lowered their price target on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a report on Thursday, August 15th. Barclays lowered their price objective on shares of LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $8.25.

Insider Transactions at LifeStance Health Group

In related news, insider Ann Varanakis sold 5,269 shares of LifeStance Health Group stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $6.28, for a total transaction of $33,089.32. Following the completion of the transaction, the insider now directly owns 263,007 shares of the company’s stock, valued at $1,651,683.96. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 6.60% of the company’s stock.

LifeStance Health Group Stock Down 2.3 %

LFST traded down $0.16 on Friday, hitting $6.85. The company had a trading volume of 1,102,373 shares, compared to its average volume of 1,486,800. The stock has a fifty day simple moving average of $6.75 and a 200-day simple moving average of $6.13. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.22 and a quick ratio of 1.22. The firm has a market capitalization of $2.62 billion, a P/E ratio of -14.27 and a beta of 1.24. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $9.20.

LifeStance Health Group (NASDAQ:LFST) last released its earnings results on Thursday, August 8th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $312.30 million during the quarter, compared to analysts’ expectations of $305.85 million. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. The firm’s revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter last year, the business posted ($0.13) EPS. As a group, equities analysts expect that LifeStance Health Group, Inc. will post -0.24 EPS for the current fiscal year.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.